 | Up a level |
Studer, Urs E.; Whelan, Peter; Wimpissinger, Florian; Casselman, Jacques; de Reijke, Theo M.; Knönagel, Hartmut; Loidl, Wolfgang; Isorna, Santiago; Sundaram, Subramanian K.; Collette, Laurence (2014). Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up. European urology, 66(5), pp. 829-838. Elsevier 10.1016/j.eururo.2013.07.024
Studer, Urs E; Collette, Laurence; Whelan, Peter; Albrecht, Walter; Casselman, Jacques; de Reijke, Theo; Knönagel, Hartmut; Loidl, Wolfgang; Isorna, Santiago; Sundaram, Subramanian K; Debois, Muriel (2008). Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). European urology, 53(5), pp. 941-9. Amsterdam: Elsevier 10.1016/j.eururo.2007.12.032
Studer, Urs E; Whelan, Peter; Albrecht, Walter; Casselman, Jacques; de Reijke, Theo; Hauri, Dieter; Loidl, Wolfgang; Isorna, Santiago; Sundaram, Subramanian K; Debois, Muriel; Collette, Laurence (2006). Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. Journal of clinical oncology, 24(12), pp. 1868-76. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.7423
